Selected research
Industry Research
Nuclear Medicine Software Industry Research Report 2026
Market perspective
The global Nuclear Medicine Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nuclear Medicine Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nuclear Medicine Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nuclear Medicine Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nuclear Medicine Software include iQ IMAGE, Mediso, Segami, Hermes Medical Solutions, MIM Software Inc, LabLogic, scintido, Gamma Gurus and Mirion Medical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nuclear Medicine Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nuclear Medicine Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nuclear Medicine Software Market by Company
iQ IMAGE
Mediso
Segami
Hermes Medical Solutions
MIM Software Inc
LabLogic
scintido
Gamma Gurus
Mirion Medical
PAIRE
GE HealthCare
Inter Medical
Sirona
Nuclear Medicine Software Segment by Type
Drug Management
Radiation Management
Other
Nuclear Medicine Software Segment by Application
Clinical Diagnosis
Research
Others
Nuclear Medicine Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nuclear Medicine Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug Management
- Radiation Management
- Other
Applications
- Clinical Diagnosis
- Research
- Others
Companies covered
- iQ IMAGE
- Mediso
- Segami
- Hermes Medical Solutions
- MIM Software Inc
- LabLogic
- scintido
- Gamma Gurus
- Mirion Medical
- PAIRE
- GE HealthCare
- Inter Medical
- Sirona
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nuclear Medicine Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Drug Management
- 2.2.3 Radiation Management
- 2.2.4 Other
- 2.3 Nuclear Medicine Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Diagnosis
- 2.3.3 Research
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Nuclear Medicine Software Breakdown Data by Type
- 3.1 Global Nuclear Medicine Software Historic Market Size by Type (2021-2026)
- 3.2 Global Nuclear Medicine Software Forecasted Market Size by Type (2027-2032)
4 Nuclear Medicine Software Breakdown Data by Application
- 4.1 Global Nuclear Medicine Software Historic Market Size by Application (2021-2026)
- 4.2 Global Nuclear Medicine Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nuclear Medicine Software Market Perspective (2021-2032)
- 5.2 Global Nuclear Medicine Software Growth Trends by Region
- 5.2.1 Global Nuclear Medicine Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nuclear Medicine Software Historic Market Size by Region (2021-2026)
- 5.2.3 Nuclear Medicine Software Forecasted Market Size by Region (2027-2032)
- 5.3 Nuclear Medicine Software Market Dynamics
- 5.3.1 Nuclear Medicine Software Industry Trends
- 5.3.2 Nuclear Medicine Software Market Drivers
- 5.3.3 Nuclear Medicine Software Market Challenges
- 5.3.4 Nuclear Medicine Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nuclear Medicine Software Players by Revenue
- 6.1.1 Global Top Nuclear Medicine Software Players by Revenue (2021-2026)
- 6.1.2 Global Nuclear Medicine Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Nuclear Medicine Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nuclear Medicine Software Head Office and Area Served
- 6.4 Global Nuclear Medicine Software Players, Product Type & Application
- 6.5 Global Nuclear Medicine Software Manufacturers Established Date
- 6.6 Global Nuclear Medicine Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nuclear Medicine Software Market Size (2021-2032)
- 7.2 North America Nuclear Medicine Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nuclear Medicine Software Market Size by Country (2021-2026)
- 7.4 North America Nuclear Medicine Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nuclear Medicine Software Market Size (2021-2032)
- 8.2 Europe Nuclear Medicine Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nuclear Medicine Software Market Size by Country (2021-2026)
- 8.4 Europe Nuclear Medicine Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nuclear Medicine Software Market Size (2021-2032)
- 9.2 Asia-Pacific Nuclear Medicine Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nuclear Medicine Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nuclear Medicine Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nuclear Medicine Software Market Size (2021-2032)
- 10.2 South America Nuclear Medicine Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nuclear Medicine Software Market Size by Country (2021-2026)
- 10.4 South America Nuclear Medicine Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nuclear Medicine Software Market Size (2021-2032)
- 11.2 Middle East & Africa Nuclear Medicine Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nuclear Medicine Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nuclear Medicine Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 iQ IMAGE
- 12.1.1 iQ IMAGE Company Information
- 12.1.2 iQ IMAGE Business Overview
- 12.1.3 iQ IMAGE Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.1.4 iQ IMAGE Nuclear Medicine Software Product Portfolio
- 12.1.5 iQ IMAGE Recent Developments
- 12.2 Mediso
- 12.2.1 Mediso Company Information
- 12.2.2 Mediso Business Overview
- 12.2.3 Mediso Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.2.4 Mediso Nuclear Medicine Software Product Portfolio
- 12.2.5 Mediso Recent Developments
- 12.3 Segami
- 12.3.1 Segami Company Information
- 12.3.2 Segami Business Overview
- 12.3.3 Segami Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.3.4 Segami Nuclear Medicine Software Product Portfolio
- 12.3.5 Segami Recent Developments
- 12.4 Hermes Medical Solutions
- 12.4.1 Hermes Medical Solutions Company Information
- 12.4.2 Hermes Medical Solutions Business Overview
- 12.4.3 Hermes Medical Solutions Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.4.4 Hermes Medical Solutions Nuclear Medicine Software Product Portfolio
- 12.4.5 Hermes Medical Solutions Recent Developments
- 12.5 MIM Software Inc
- 12.5.1 MIM Software Inc Company Information
- 12.5.2 MIM Software Inc Business Overview
- 12.5.3 MIM Software Inc Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.5.4 MIM Software Inc Nuclear Medicine Software Product Portfolio
- 12.5.5 MIM Software Inc Recent Developments
- 12.6 LabLogic
- 12.6.1 LabLogic Company Information
- 12.6.2 LabLogic Business Overview
- 12.6.3 LabLogic Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.6.4 LabLogic Nuclear Medicine Software Product Portfolio
- 12.6.5 LabLogic Recent Developments
- 12.7 scintido
- 12.7.1 scintido Company Information
- 12.7.2 scintido Business Overview
- 12.7.3 scintido Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.7.4 scintido Nuclear Medicine Software Product Portfolio
- 12.7.5 scintido Recent Developments
- 12.8 Gamma Gurus
- 12.8.1 Gamma Gurus Company Information
- 12.8.2 Gamma Gurus Business Overview
- 12.8.3 Gamma Gurus Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.8.4 Gamma Gurus Nuclear Medicine Software Product Portfolio
- 12.8.5 Gamma Gurus Recent Developments
- 12.9 Mirion Medical
- 12.9.1 Mirion Medical Company Information
- 12.9.2 Mirion Medical Business Overview
- 12.9.3 Mirion Medical Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.9.4 Mirion Medical Nuclear Medicine Software Product Portfolio
- 12.9.5 Mirion Medical Recent Developments
- 12.10 PAIRE
- 12.10.1 PAIRE Company Information
- 12.10.2 PAIRE Business Overview
- 12.10.3 PAIRE Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.10.4 PAIRE Nuclear Medicine Software Product Portfolio
- 12.10.5 PAIRE Recent Developments
- 12.11 GE HealthCare
- 12.11.1 GE HealthCare Company Information
- 12.11.2 GE HealthCare Business Overview
- 12.11.3 GE HealthCare Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.11.4 GE HealthCare Nuclear Medicine Software Product Portfolio
- 12.11.5 GE HealthCare Recent Developments
- 12.12 Inter Medical
- 12.12.1 Inter Medical Company Information
- 12.12.2 Inter Medical Business Overview
- 12.12.3 Inter Medical Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.12.4 Inter Medical Nuclear Medicine Software Product Portfolio
- 12.12.5 Inter Medical Recent Developments
- 12.13 Sirona
- 12.13.1 Sirona Company Information
- 12.13.2 Sirona Business Overview
- 12.13.3 Sirona Revenue in Nuclear Medicine Software Business (2021-2026)
- 12.13.4 Sirona Nuclear Medicine Software Product Portfolio
- 12.13.5 Sirona Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst